Cargando…

Mitophagy in atherosclerosis: from mechanism to therapy

Mitophagy is a type of autophagy that can selectively eliminate damaged and depolarized mitochondria to maintain mitochondrial activity and cellular homeostasis. Several pathways have been found to participate in different steps of mitophagy. Mitophagy plays a significant role in the homeostasis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanhong, Weng, Jiajun, Huan, Luyao, Sheng, Song, Xu, Fengqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228545/
https://www.ncbi.nlm.nih.gov/pubmed/37261351
http://dx.doi.org/10.3389/fimmu.2023.1165507
_version_ 1785050988589088768
author Zhang, Yanhong
Weng, Jiajun
Huan, Luyao
Sheng, Song
Xu, Fengqin
author_facet Zhang, Yanhong
Weng, Jiajun
Huan, Luyao
Sheng, Song
Xu, Fengqin
author_sort Zhang, Yanhong
collection PubMed
description Mitophagy is a type of autophagy that can selectively eliminate damaged and depolarized mitochondria to maintain mitochondrial activity and cellular homeostasis. Several pathways have been found to participate in different steps of mitophagy. Mitophagy plays a significant role in the homeostasis and physiological function of vascular endothelial cells, vascular smooth muscle cells, and macrophages, and is involved in the development of atherosclerosis (AS). At present, many medications and natural chemicals have been shown to alter mitophagy and slow the progression of AS. This review serves as an introduction to the field of mitophagy for researchers interested in targeting this pathway as part of a potential AS management strategy.
format Online
Article
Text
id pubmed-10228545
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102285452023-05-31 Mitophagy in atherosclerosis: from mechanism to therapy Zhang, Yanhong Weng, Jiajun Huan, Luyao Sheng, Song Xu, Fengqin Front Immunol Immunology Mitophagy is a type of autophagy that can selectively eliminate damaged and depolarized mitochondria to maintain mitochondrial activity and cellular homeostasis. Several pathways have been found to participate in different steps of mitophagy. Mitophagy plays a significant role in the homeostasis and physiological function of vascular endothelial cells, vascular smooth muscle cells, and macrophages, and is involved in the development of atherosclerosis (AS). At present, many medications and natural chemicals have been shown to alter mitophagy and slow the progression of AS. This review serves as an introduction to the field of mitophagy for researchers interested in targeting this pathway as part of a potential AS management strategy. Frontiers Media S.A. 2023-05-16 /pmc/articles/PMC10228545/ /pubmed/37261351 http://dx.doi.org/10.3389/fimmu.2023.1165507 Text en Copyright © 2023 Zhang, Weng, Huan, Sheng and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zhang, Yanhong
Weng, Jiajun
Huan, Luyao
Sheng, Song
Xu, Fengqin
Mitophagy in atherosclerosis: from mechanism to therapy
title Mitophagy in atherosclerosis: from mechanism to therapy
title_full Mitophagy in atherosclerosis: from mechanism to therapy
title_fullStr Mitophagy in atherosclerosis: from mechanism to therapy
title_full_unstemmed Mitophagy in atherosclerosis: from mechanism to therapy
title_short Mitophagy in atherosclerosis: from mechanism to therapy
title_sort mitophagy in atherosclerosis: from mechanism to therapy
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228545/
https://www.ncbi.nlm.nih.gov/pubmed/37261351
http://dx.doi.org/10.3389/fimmu.2023.1165507
work_keys_str_mv AT zhangyanhong mitophagyinatherosclerosisfrommechanismtotherapy
AT wengjiajun mitophagyinatherosclerosisfrommechanismtotherapy
AT huanluyao mitophagyinatherosclerosisfrommechanismtotherapy
AT shengsong mitophagyinatherosclerosisfrommechanismtotherapy
AT xufengqin mitophagyinatherosclerosisfrommechanismtotherapy